Mark A. Goldsmith - 06 Dec 2021 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role
President and Chief Executive Officer, Director
Signature
/s/ Jack Anders, as attorney-in fact for Mark A. Goldsmith
Issuer symbol
RVMD
Transactions as of
06 Dec 2021
Net transactions value
+$18,483
Form type
4
Filing time
08 Dec 2021, 15:16:06 UTC
Previous filing
21 Sep 2021
Next filing
21 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $18,483 +37,721 +81% $0.4900* 84,193 06 Dec 2021 Direct F4
holding RVMD Common Stock 37,032 06 Dec 2021 Trust F1
holding RVMD Common Stock 37,032 06 Dec 2021 Trust F2
holding RVMD Common Stock 266,506 06 Dec 2021 Trust F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -37,721 -18% $0.000000 167,782 06 Dec 2021 Common Stock 37,721 $0.4900 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F2 Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
F3 Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
F4 Includes 42,000 RSUs.

Remarks:

President and Chief Executive Officer